vs

Side-by-side financial comparison of INSMED Inc (INSM) and EXPRO GROUP HOLDINGS N.V. (XPRO). Click either name above to swap in a different company.

EXPRO GROUP HOLDINGS N.V. is the larger business by last-quarter revenue ($367.6M vs $263.8M, roughly 1.4× INSMED Inc). On growth, INSMED Inc posted the faster year-over-year revenue change (152.6% vs -6.0%). EXPRO GROUP HOLDINGS N.V. produced more free cash flow last quarter ($23.2M vs $-264.2M). Over the past eight quarters, INSMED Inc's revenue compounded faster (86.9% CAGR vs -11.5%).

Insmed Inc. is a global biopharmaceutical firm focused on developing and commercializing innovative therapies for patients with serious rare diseases that have high unmet medical needs. Its key offerings target pulmonary and endocrine rare disorders, serving markets across North America, Europe, and Asia Pacific.

Expro is an energy services provider headquartered in Houston, Texas, United States.

INSM vs XPRO — Head-to-Head

Bigger by revenue
XPRO
XPRO
1.4× larger
XPRO
$367.6M
$263.8M
INSM
Growing faster (revenue YoY)
INSM
INSM
+158.6% gap
INSM
152.6%
-6.0%
XPRO
More free cash flow
XPRO
XPRO
$287.4M more FCF
XPRO
$23.2M
$-264.2M
INSM
Faster 2-yr revenue CAGR
INSM
INSM
Annualised
INSM
86.9%
-11.5%
XPRO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
INSM
INSM
XPRO
XPRO
Revenue
$263.8M
$367.6M
Net Profit
$-328.5M
Gross Margin
83.2%
6.7%
Operating Margin
-121.2%
0.0%
Net Margin
-124.5%
Revenue YoY
152.6%
-6.0%
Net Profit YoY
-39.5%
EPS (diluted)
$-1.55
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INSM
INSM
XPRO
XPRO
Q1 26
$367.6M
Q4 25
$263.8M
$382.1M
Q3 25
$142.3M
$411.4M
Q2 25
$107.4M
$422.7M
Q1 25
$92.8M
$390.9M
Q4 24
$104.4M
$436.8M
Q3 24
$93.4M
$422.8M
Q2 24
$90.3M
$469.6M
Net Profit
INSM
INSM
XPRO
XPRO
Q1 26
Q4 25
$-328.5M
$5.8M
Q3 25
$-370.0M
$14.0M
Q2 25
$-321.7M
$18.0M
Q1 25
$-256.6M
$13.9M
Q4 24
$-235.5M
$23.0M
Q3 24
$-220.5M
$16.3M
Q2 24
$-300.6M
$15.3M
Gross Margin
INSM
INSM
XPRO
XPRO
Q1 26
6.7%
Q4 25
83.2%
Q3 25
79.4%
Q2 25
73.9%
Q1 25
77.1%
Q4 24
75.0%
Q3 24
77.3%
Q2 24
76.8%
Operating Margin
INSM
INSM
XPRO
XPRO
Q1 26
0.0%
Q4 25
-121.2%
3.1%
Q3 25
-257.1%
6.4%
Q2 25
-291.3%
7.7%
Q1 25
-267.3%
2.6%
Q4 24
-220.6%
7.3%
Q3 24
-228.4%
6.2%
Q2 24
-319.8%
5.9%
Net Margin
INSM
INSM
XPRO
XPRO
Q1 26
Q4 25
-124.5%
1.5%
Q3 25
-260.0%
3.4%
Q2 25
-299.5%
4.3%
Q1 25
-276.4%
3.6%
Q4 24
-225.5%
5.3%
Q3 24
-236.0%
3.8%
Q2 24
-332.8%
3.3%
EPS (diluted)
INSM
INSM
XPRO
XPRO
Q1 26
$0.05
Q4 25
$-1.55
$0.05
Q3 25
$-1.75
$0.12
Q2 25
$-1.70
$0.16
Q1 25
$-1.42
$0.12
Q4 24
$-1.30
$0.20
Q3 24
$-1.27
$0.14
Q2 24
$-1.94
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INSM
INSM
XPRO
XPRO
Cash + ST InvestmentsLiquidity on hand
$1.4B
$170.7M
Total DebtLower is stronger
$546.8M
$79.1M
Stockholders' EquityBook value
$739.0M
$1.5B
Total Assets
$2.3B
$2.2B
Debt / EquityLower = less leverage
0.74×
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INSM
INSM
XPRO
XPRO
Q1 26
$170.7M
Q4 25
$1.4B
$196.1M
Q3 25
$1.7B
$197.9M
Q2 25
$1.9B
$206.8M
Q1 25
$1.2B
$179.3M
Q4 24
$1.4B
$183.0M
Q3 24
$1.5B
$165.7M
Q2 24
$1.2B
$133.5M
Total Debt
INSM
INSM
XPRO
XPRO
Q1 26
$79.1M
Q4 25
$546.8M
$79.1M
Q3 25
$546.8M
$99.1M
Q2 25
$546.8M
$121.1M
Q1 25
$1.1B
$121.1M
Q4 24
$1.1B
$121.1M
Q3 24
$971.8M
$121.1M
Q2 24
$1.2B
$121.1M
Stockholders' Equity
INSM
INSM
XPRO
XPRO
Q1 26
$1.5B
Q4 25
$739.0M
$1.5B
Q3 25
$945.6M
$1.5B
Q2 25
$1.2B
$1.5B
Q1 25
$99.2M
$1.5B
Q4 24
$285.4M
$1.5B
Q3 24
$483.4M
$1.5B
Q2 24
$38.8M
$1.5B
Total Assets
INSM
INSM
XPRO
XPRO
Q1 26
$2.2B
Q4 25
$2.3B
$2.3B
Q3 25
$2.4B
$2.3B
Q2 25
$2.5B
$2.3B
Q1 25
$1.8B
$2.3B
Q4 24
$2.0B
$2.3B
Q3 24
$2.1B
$2.3B
Q2 24
$1.8B
$2.3B
Debt / Equity
INSM
INSM
XPRO
XPRO
Q1 26
0.05×
Q4 25
0.74×
0.05×
Q3 25
0.58×
0.07×
Q2 25
0.44×
0.08×
Q1 25
11.31×
0.08×
Q4 24
3.93×
0.08×
Q3 24
2.01×
0.08×
Q2 24
30.66×
0.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INSM
INSM
XPRO
XPRO
Operating Cash FlowLast quarter
$-247.6M
$25.3M
Free Cash FlowOCF − Capex
$-264.2M
$23.2M
FCF MarginFCF / Revenue
-100.1%
6.3%
Capex IntensityCapex / Revenue
6.3%
1.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-967.6M
$112.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INSM
INSM
XPRO
XPRO
Q1 26
$25.3M
Q4 25
$-247.6M
$57.1M
Q3 25
$-219.8M
$63.2M
Q2 25
$-205.6M
$48.4M
Q1 25
$-262.1M
$41.5M
Q4 24
$-196.0M
$97.4M
Q3 24
$-180.9M
$55.3M
Q2 24
$-123.0M
$-13.2M
Free Cash Flow
INSM
INSM
XPRO
XPRO
Q1 26
$23.2M
Q4 25
$-264.2M
$23.2M
Q3 25
$-222.2M
$39.0M
Q2 25
$-209.1M
$27.2M
Q1 25
$-272.2M
$8.4M
Q4 24
$-202.8M
$53.0M
Q3 24
$-184.6M
$23.3M
Q2 24
$-129.7M
$-49.5M
FCF Margin
INSM
INSM
XPRO
XPRO
Q1 26
6.3%
Q4 25
-100.1%
6.1%
Q3 25
-156.1%
9.5%
Q2 25
-194.6%
6.4%
Q1 25
-293.2%
2.1%
Q4 24
-194.1%
12.1%
Q3 24
-197.6%
5.5%
Q2 24
-143.6%
-10.5%
Capex Intensity
INSM
INSM
XPRO
XPRO
Q1 26
1.2%
Q4 25
6.3%
8.9%
Q3 25
1.7%
5.9%
Q2 25
3.2%
5.0%
Q1 25
10.8%
8.5%
Q4 24
6.5%
10.2%
Q3 24
3.9%
7.6%
Q2 24
7.5%
7.7%
Cash Conversion
INSM
INSM
XPRO
XPRO
Q1 26
Q4 25
9.89×
Q3 25
4.52×
Q2 25
2.69×
Q1 25
2.98×
Q4 24
4.23×
Q3 24
3.40×
Q2 24
-0.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons